New Chicco Bottles Study (Step-Up)

October 17, 2017 updated by: Sprim Advanced Life Sciences

Evaluation of the New Chicco Breast-like and Evolutive Feeding Bottles on Physiological Feeding Parameters and Colic-like Symptoms in Infants

Breastfeeding is recommended as the ideal form of nutrition for newborns and infants at least for the first 6 months of life by several Institutions such as the American Academy of Pediatrics (AAP) and the World Health Organization (WHO).

When breastfeeding is not possible or not desirable, bottle-feeding, in most cases using a proper infant formula, is the right alternative.

Both facial and cranial growth and development rely on genetic and external stimuli; the latter are provided also by activities of sucking, swallowing and chewing. Considering this, it is important to show the differences between the activities of the muscles (masseter, temporalis and buccinator) in charge of sucking during breastfeeding or bottle-feeding.

The activities of the muscles were evaluated through SLI, which consists of the assessment of muscle functioning by analyzing the displacement of a defined point on a given muscle. This displacement is tracked over time with respect to a fixed frame of reference, thus providing velocity data (i.e. speed) for a certain point on the muscle during muscle contraction. The use of SLI allowed us to determine the activity of oral muscles on the different types of feeding and to compare their strength and activity.

Principal aims of the present study was to assess the activity of the orbicularis oris muscle (OM) and of the masseter, temporalis and buccinator muscles (MM, TM and BM) (i.e. the muscles in charge of sucking during breastfeeding) during breastfeeding and bottle-feeding by means of SLI. The new Chicco feeding bottles Natural Feeling (Natural Fit) 0m+, 4m+ and 6m+ were used according to the age of the infants.

Moreover, the following parameters were evaluated comparing breastfeeding and bottle-feeding: feeding efficiency (measured as ml/minute milk intake considering an interval of 15 minutes) and oxygen saturation during feeding (assessed by pulse oximetry). Moreover colic-like symptoms over 9 weeks (0 to 4 weeks infant only) were evaluated through the Infant Colic Scale.

Study Overview

Detailed Description

By means of SLI technique positive preliminary results as regards comparison between bottle feeding with the New Chicco Bottles and breastfeeding were reached; these results allow to conclude that, considering feeding features related to growth and development, bottle-feeding with the new Chicco bottles can biomimic the suction muscular dynamics of breastfeeding.

A proper growth is confirmed in bottle-feeding groups also by means of evaluations of growth parameters, and it is guaranteed by the evaluation of the oxygen saturation during feeding, that is similar among groups.

As regards evaluation of colic underlying causes in infants ages 0-4 weeks it is possible to state that no differences were found in bottle-fed and breastfed infants: given the lack of differences between the groups, whichever the underlying reason for colic symptomatology could exist, it is possible to infer that using one or the other kind of feeding does not have an impact on symptoms, or had a minor one.

As regards the product satisfaction evaluated comparing the bottle-fed groups positive results were reached in all the evaluation, at V2, Week 5 and Week 9, reaching always a mean score > 8.

Notwithstanding the positive results above outlined a confirmatory study, envisaging a bigger sample size, it is advisable, to confirm and emphasize the results already achieved.

For each trial participant the adverse events/serious adverse events occurrences and a brief clinical examination were assessed during Visits. No special or unusual features of the safety evaluations were found.

Study Type

Interventional

Enrollment (Actual)

61

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 day to 10 months (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male and female infants aged 0 to 10 months according to the following:

Group 1: age 0-4 weeks (+/- 7 days) Group 2: age 4 months (+/- 10 days) Group 3: age 6-10 months (+/- 10 days) Group 4: age 0-4 weeks (+/- 7 days) Group 5: age 4 months (+/- 10 days) Group 6: age 6-10 months (+/- 10 days)

  • Infants exclusively or prevalently breast- or bottle-fed
  • Full-term infants (≥ 37 weeks of gestation) with APGAR at birth (5 min) ≥ 8 by parent report
  • Birth weight ≥ 2.5 kg by parent report
  • Capability of the parents / legal guardians, according to Investigator's opinion, to fully comprehend the nature of the study
  • Parents / legal guardians' written consent to the study and willingness to comply with study procedures

Exclusion Criteria:

  • Birth defect, injury or health condition that interferes with sucking, feeding or breathing
  • Any medical condition or disease that may affect subject safety or confound study results, including cardiac or neurological defects
  • Infants born from twin or multiple pregnancy
  • Any other condition that, in the Investigator's opinion, may preclude the subject's ability to safely complete the trial
  • Parents / legal guardians uncooperative and/or non-compliant according to Investigator's opinion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Feeding Bottle 0m+
10 infants aged 0-4 weeks (+/- 7 days): 0-4 m bottle. 0-4 months, 250 ml, 2 angled teats: newborn (also referred to as low flow) and infant (also referred to as medium flow), for infants aged 0-4 weeks (+/- 7 days) / over 9 weeks of participation.
  • angled/inclined teat that remains full of milk throughout the feeding to prevent the risk of air ingestion, gassy colic, hiccups and regurgitation and to keep the infant's neck in the right position;
  • extra-large, soft and rounded base to ensure maximum simulation of the maternal breast and a wide latch on for a correct suckling motion
  • flexors at the base to enhance elasticity and flexibility of the teat
Other Names:
  • Natural Feeling/Natural Fit 0-4m:
Experimental: Feeding Bottle 4m+
10 infants aged 4 months (+/- 10 days): 4-6 m bottle. 4-6 months, 250 ml, non-angled teat), for infants aged 4 months (+/- 10 days) / over 9 weeks of participation.
  • large, rounded and soft teat to ensure maximum simulation of the maternal breast and a wide latch on for a correct suckling motion
  • non-inclined shape of the teat ideal from 4 months onwards, when the colic episodes have subsided and infant has more control of the neck.
  • flexors at the base to enhance elasticity and flexibility of the teat
Other Names:
  • Natural Feeling/Natural Fit 4-6m:
  • teat with less rounded base to guarantee tighter lip support, which helps the "sucking" motion.
  • flexors at the base to enhance elasticity and flexibility of the teat
Other Names:
  • Natural Feeling/Natural Fit 6m+:
Experimental: Feeding Bottle 6m+
10 infants aged 6-10 months (+/- 10 days): 6m+ bottle. 6 months and over, 250 ml, longer teat) for infants aged form 6 to 10 months (+/- 10 days) / over 9 weeks of participation.
  • large, rounded and soft teat to ensure maximum simulation of the maternal breast and a wide latch on for a correct suckling motion
  • non-inclined shape of the teat ideal from 4 months onwards, when the colic episodes have subsided and infant has more control of the neck.
  • flexors at the base to enhance elasticity and flexibility of the teat
Other Names:
  • Natural Feeling/Natural Fit 4-6m:
  • teat with less rounded base to guarantee tighter lip support, which helps the "sucking" motion.
  • flexors at the base to enhance elasticity and flexibility of the teat
Other Names:
  • Natural Feeling/Natural Fit 6m+:
No Intervention: exclusively or prevalently breast-fed infants 0m+
10 infants aged 0-4 weeks (+/- 7 days)
No Intervention: exclusively or prevalently breast-fed infants 4m+
10 infants aged 4 months (+/- 10 days)
No Intervention: exclusively or prevalently breast-fed infants 6m+
10 infants aged 6-10 months (+/- 10 days) (at least 2 breastfeeding sessions per day)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Velocity orbicularis oris (OM) Muscle by means of SLI
Time Frame: Week 2

To assess the orbicularis oris muscle (OM) and the perioral muscles (masseter, temporalis and buccinator muscles - MM, TM and BM) activity during breast- or bottle-feeding through SLI of the face during a single feeding session considering 3 treatment groups + 3 comparison groups:

Treatment groups: bottle-fed infants

  • Group 1: age 0-4 weeks (+/- 7 days): 0-4 m bottle
  • Group 2: age 4 months (+/- 10 days): 4-6 m bottle
  • Group 3: age 6-10 months (+/- 10 days): 6m+ bottle Control groups: exclusively or prevalently breast-fed infants
  • Group 4: age 0-4 weeks (+/- 7 days)
  • Group 5: age 4 months (+/- 10 days)
  • Group 6: age 6-10 months (+/- 10 days) (at least 2 breastfeeding sessions per day)
Week 2
Mean Velocity masseter MM Muscle by means of SLI
Time Frame: week 2

To assess the orbicularis oris muscle (OM) and the perioral muscles (masseter, temporalis and buccinator muscles - MM, TM and BM) activity during breast- or bottle-feeding through SLI of the face during a single feeding session considering 3 treatment groups + 3 comparison groups:

Treatment groups: bottle-fed infants

  • Group 1: age 0-4 weeks (+/- 7 days): 0-4 m bottle
  • Group 2: age 4 months (+/- 10 days): 4-6 m bottle
  • Group 3: age 6-10 months (+/- 10 days): 6m+ bottle Control groups: exclusively or prevalently breast-fed infants
  • Group 4: age 0-4 weeks (+/- 7 days)
  • Group 5: age 4 months (+/- 10 days)
  • Group 6: age 6-10 months (+/- 10 days) (at least 2 breastfeeding sessions per day)
week 2
Mean Velocity Temporalis Muscle by means of SLI
Time Frame: week 2

To assess the orbicularis oris muscle (OM) and the perioral muscles (masseter, temporalis and buccinator muscles - MM, TM and BM) activity during breast- or bottle-feeding through SLI of the face during a single feeding session considering 3 treatment groups + 3 comparison groups:

Treatment groups: bottle-fed infants

  • Group 1: age 0-4 weeks (+/- 7 days): 0-4 m bottle
  • Group 2: age 4 months (+/- 10 days): 4-6 m bottle
  • Group 3: age 6-10 months (+/- 10 days): 6m+ bottle Control groups: exclusively or prevalently breast-fed infants
  • Group 4: age 0-4 weeks (+/- 7 days)
  • Group 5: age 4 months (+/- 10 days)
  • Group 6: age 6-10 months (+/- 10 days) (at least 2 breastfeeding sessions per day)
week 2
Mean Velocity Buccinator Muscle by means of SLI
Time Frame: week 2

To assess the orbicularis oris muscle (OM) and the perioral muscles (masseter, temporalis and buccinator muscles - MM, TM and BM) activity during breast- or bottle-feeding through SLI of the face during a single feeding session considering 3 treatment groups + 3 comparison groups:

Treatment groups: bottle-fed infants

  • Group 1: age 0-4 weeks (+/- 7 days): 0-4 m bottle
  • Group 2: age 4 months (+/- 10 days): 4-6 m bottle
  • Group 3: age 6-10 months (+/- 10 days): 6m+ bottle Control groups: exclusively or prevalently breast-fed infants
  • Group 4: age 0-4 weeks (+/- 7 days)
  • Group 5: age 4 months (+/- 10 days)
  • Group 6: age 6-10 months (+/- 10 days) (at least 2 breastfeeding sessions per day)
week 2

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ml/minute milk intake during an interval of 15 minutes
Time Frame: week 2
To evaluate feeding efficiency (ml/minute milk intake for 15 minutes) during a single feeding session of breast- or bottle-feeding considering each group; week 2;
week 2
oxygen saturation
Time Frame: week 2
To evaluate oxygen saturation through pulse oximetry during a single feeding session of breast- or bottle-feeding considering 3 treatment groups + 3 comparison groups (1, 2, 3, 4, 5, 6); this evaluation was be done at week 2;
week 2
infant colic scale
Time Frame: week 5

To evaluate colic-like symptoms over 9 weeks considering breast- or bottle-feeding groups in 0 to 4 weeks infants only (groups 1 and 4), through the validated Infant Colic Scale at week 5.

The following items were considered:

  • Cow's milk/soy protein allergy intolerance: Max score 12 Min score 2
  • Immature gastrointestinal system Max score 24 Min score 4
  • Immature central nervous system Max score 48 Min score 8
  • Difficult infant temperament Max score 24 Min score 4
  • Parent infant interaction/Problem infant Max score 24 Min score 4
  • Total score Max score 132 Min score 22 The difference between the study groups were evaluated. The scale was used to evaluate a possible difference between bottle- and breastfed infants, there's no "better" or "worse" outcome. Subscales are summed to compute a total score.
week 5
infant colic scale
Time Frame: week9

To evaluate colic-like symptoms over 9 weeks considering breast- or bottle-feeding groups in 0 to 4 weeks infants only (groups 1 and 4), through the validated Infant Colic Scale at week 9.

The following items were considered:

  • Cow's milk/soy protein allergy intolerance: Max score 12 Min score 2
  • Immature gastrointestinal system Max score 24 Min score 4
  • Immature central nervous system Max score 48 Min score 8
  • Difficult infant temperament Max score 24 Min score 4
  • Parent infant interaction/Problem infant Max score 24 Min score 4
  • Total score Max score 132 Min score 22 The difference between the study groups were evaluated. The scale was used to evaluate a possible difference between bottle- and breastfed infants, there's no "better" or "worse" outcome. Subscales are summed to compute a total score.
week9
overall product satisfaction (10 points likert scales)
Time Frame: week 2
Overall product satisfaction at week 2. It is assessed on 0 to 10 points Likert scale; minimum value is 0, maximum is 10, corresponding to minimum and maximum satisfaction. The better outcome corresponds to a score equal to 10.
week 2
overall product satisfaction (10 points likert scales)
Time Frame: week 5
Overall product satisfaction at week 5. It is assessed on 0 to 10 points Likert scale; minimum value is 0, maximum is 10, corresponding to minimum and maximum satisfaction. The better outcome corresponds to a score equal to 10
week 5
overall product satisfaction (10 points Likert scales)
Time Frame: week 9
Overall product satisfaction at week 9. It is assessed on 0 to 10 points Likert scale; minimum value is 0, maximum is 10, corresponding to minimum and maximum satisfaction. The better outcome corresponds to a score equal to 10
week 9
Ability of infant to latch onto bottle (10 points Likert scales)
Time Frame: week 2
Ability of infant to latch onto bottle at week 2. It is assessed on 0 to 10 points Likert scale; minimum value is 0, maximum is 10, corresponding to minimum and maximum satisfaction. The better outcome corresponds to a score equal to 10
week 2
Ability of infant to latch onto bottle (10 points Likert scales)
Time Frame: week 5
Ability of infant to latch onto bottle at week 5
week 5
Ability of infant to latch onto bottle (10 points Likert scales)
Time Frame: week 9
Ability of infant to latch onto bottle at week 9. It is assessed on 0 to 10 points Likert scale; minimum value is 0, maximum is 10, corresponding to minimum and maximum satisfaction. The better outcome corresponds to a score equal to 10
week 9
Infant comfort (10 points Likert scales)
Time Frame: week 2
Infant comfort during feeding at week 2
week 2
Infant comfort (10 points Likert scales)
Time Frame: week 5
Infant comfort during feeding at week 5. It is assessed on 0 to 10 points Likert scale; minimum value is 0, maximum is 10, corresponding to minimum and maximum satisfaction. The better outcome corresponds to a score equal to 10
week 5
Infant comfort (10 points Likert scales)
Time Frame: week 9
Infant comfort during feeding at week 9. It is assessed on 0 to 10 points Likert scale; minimum value is 0, maximum is 10, corresponding to minimum and maximum satisfaction. The better outcome corresponds to a score equal to 10
week 9
Ease of use by infant (10 points Likert scales)
Time Frame: week 2
Ease of use by infant at week 2. It is assessed on 0 to 10 points Likert scale; minimum value is 0, maximum is 10, corresponding to minimum and maximum satisfaction. The better outcome corresponds to a score equal to 10
week 2
Immediate acceptance by the infant (10 points Likert scales)
Time Frame: week 2
Immediate acceptance by the infant at week 2. It is assessed on 0 to 10 points Likert scale; minimum value is 0, maximum is 10, corresponding to minimum and maximum satisfaction. The better outcome corresponds to a score equal to 10
week 2

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 12, 2014

Primary Completion (Actual)

October 25, 2014

Study Completion (Actual)

January 5, 2015

Study Registration Dates

First Submitted

October 4, 2017

First Submitted That Met QC Criteria

October 10, 2017

First Posted (Actual)

October 17, 2017

Study Record Updates

Last Update Posted (Actual)

October 18, 2017

Last Update Submitted That Met QC Criteria

October 17, 2017

Last Verified

October 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • ART001

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Feeding Behavior

Clinical Trials on infants bottles

Subscribe